Solutions for the Health Industry

January 23 - 24, 2018

13th Biosimilars Summit

at Hilton Alexandria Old Town in Alexandria, VA

Moving Beyond Theory — Strategic and Tactical Decisions for Long-Term Success

With more U.S. biosimilars continuing to receive FDA approval, it is critical that bio/pharmaceutical companies develop strategies to comply with evolving regulations, mitigate risk and execute long-term decisions to prepare for success. CBI’s 13th Biosimilars Summit is the leading event to continually stay on the pulse of the biosimilars’ ever-changing market and convenes key stakeholders including biosimilar and innovator pharmaceutical manufacturers, payers, providers and patient advocates addressing timely challenges and best practices for biosimilar product success.

Who should attend:

You will benefit from attending this event if you are a vice president, director, or manager of a pharmaceutical or biotech company with responsibilities in the following areas:

  • Biosimilar Development
  • Brand/Marketing
  • Sales
  • Regulatory Affairs
  • Legal
  • Intellectual Property
  • Business Development
  • Portfolio Management
  • Corporate Strategy
  • Strategic Planning
  • Patents
  • Policy
  • Finance
  • Pricing Strategy
  • Managed Markets

This conference will also benefit pharmacies, GPOs, health systems, law firms, consultants, discovery firms and software service providers.

Address:

Hilton Alexandria Old Town
1767 King St.
Alexandria, VA
View map

top